ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Family Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

7,727Medicare Part D Prescriptions Filled, Including Refills

Rank: 808 out of 6969

$439K Total Retail Price of All Prescriptions

Rank: 790 out of 6969

136 Patients Receiving at Least One Drug in Part D
87%Patients 65 Years and Older
98% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in California
Lower avg

Schedule Two
Controlled Substances

8% of this provider’s 136 patients filled at least one prescription for a schedule two drug, compared to an average of 3%.

Schedule Three
Controlled Substances

24% of this provider’s 136 patients filled at least one prescription for a schedule three drug, compared to an average of 14%.

Risky Drugs to Seniors

0% of this provider’s 6,895 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 23%.

Prescription Price

$57 was the average price of a prescription from this provider, compared to $57 among peers.

Prescriptions per Patient

57 is the average number of prescriptions (including refills) per patient, compared to an average of 15.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in California
LISINOPRIL 456 422 1 2
LEVOTHYROXINE SODIUM 376 341 2 5
SIMVASTATIN 286 259 3 1
CARVEDILOL 285 262 4 25
AMLODIPINE BESYLATE 267 258 5 4
CRESTOR 266 228 6 39
HYDROCHLOROTHIAZIDE 160 148 7 8
DIVALPROEX SODIUM 155 118 8 103
NOVOLIN 70-30 149 106 9 315
HYDRALAZINE HCL 148 135 10 106
LACTULOSE 145 127 11 131
HYDROCODONE-ACETAMINOPHEN 144 137 S3 12 3
OMEPRAZOLE 123 112 13 6
FUROSEMIDE 121 108 14 10
ATORVASTATIN CALCIUM 118 114 15 11
CARBIDOPA-LEVODOPA 107 95 16 119
MIRTAZAPINE 107 98 16 76
LEVETIRACETAM 99 64 18 128
METOCLOPRAMIDE HCL 95 52 19 136
RISPERIDONE 92 91 20 88
FENTANYL 91 77 S2 21 113
QUETIAPINE FUMARATE 90 88 22 101
GABAPENTIN 84 68 23 17
ADVAIR DISKUS 83 73 24 45
NOVOLOG 81 62 25 166
SERTRALINE HCL 71 71 26 38
METFORMIN HCL 70 64 27 7
TAMSULOSIN HCL 68 67 28 23
RAMIPRIL 65 63 29 112
LATANOPROST 64 64 30 268
SPIRIVA 63 63 31 66
ATENOLOL 60 60 32 9
CITALOPRAM HBR 59 54 33 34
LIPITOR 59 51 33 89
HUMULIN 70-30 58 58 35 294
OLANZAPINE 56 31 36 139
FENOFIBRATE 55 38 37 63
PRAVASTATIN SODIUM 50 48 38 19
AMOX TR-POTASSIUM CLAVULANATE 50 44 38 194
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on April 8, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.